Navigation Links
Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-601 Repositioned Drug for Epilepsy
Date:6/23/2009

disorder.

In the animal proof of concept trial, BVA-601 was compared to diazepam, a potent anti-epileptic drug that is efficient in reducing epileptic activity but has troubling adverse events. BVA-601 induced a statistically significant reduction in the number of animals showing epileptic activity and delayed the onset of epileptic seizures.

About Biovista's repositioning pipeline and technology platform

Biovista applies high-efficiency discovery efforts to finding solutions for commercially relevant unmet medical needs. Biovista's proprietary repositioning technology allows it to perform mechanism-of-action based analyses and systematically assess clinical outcomes in any therapeutic area of interest, at relatively low cost and short time spans. The company is presently using this platform to develop its own pipeline of repositioned drugs in areas such as CNS, cardiovascular disease, oncology and autoimmune diseases.


'/>"/>
SOURCE Biovista Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis
2. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
3. Dragon Pharma Announces Results of 2009 Annual General Meeting
4. Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
5. Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion
6. Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)
7. Victhom announces completion of joint venture agreement with Otto Bock for Neurobionix activities
8. Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St. John Wound Center
9. Shamir Optical Industry Ltd. Announces Availability of Its Annual Report on Form 20-F Through Its Website
10. Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial
11. Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Lionbridge (Nasdaq: LIOX ) today ... three-year master services agreement with a multi-billion ... that serve patients in approximately 100 countries. ... sole provider for translation of the company,s ... human resources, legal, and corporate communications information. ...
(Date:12/14/2009)... 14 , - Results ... With Rheumatoid Arthritis in Seven Major Industrialized Countries , , ... rheumatoid arthritis say their disease, ... - Women living with rheumatoid arthritis find shopping for gifts, ... and wrapping presents most, difficult ...
(Date:12/11/2009)... -- Researchers have discovered a new explanation for differences in ... copies of a certain gene, the more serious the handicap. ... is suspected that it is the amount of copies of ... published in the American Journal of Human Genetics , ... Guy Froyen connected to VIB, a life sciences research institute ...
(Date:12/11/2009)... Calif., Dec. 11 Marrone Bio Innovations ... executive management team. Mr. Chris Hildreth joined MBI ... is responsible for expanding all commercial aspects of ... functions. Dr. Kin Sing (Ray) Lam joined MBI ... the company,s development efforts in scaling its broad ...
Breaking Biology Technology:Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Amount of gene surplus determines severity of mental retardation in males 2Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3
... The nano centres of the universities in the resund ... and Lund University together with MC2 at Chalmers ... join forces to build up a network for co-operation ... of the future , Used efficiently, knowledge ...
... 26 CV Therapeutics,Inc. (Nasdaq: CVTX ) ... 4350, the Company issued new inducement stock options ... in connection,with its commercialization efforts in the United ... aggregate 23,600 shares of common,stock and are classified ...
... "FOR" Votes Required for Integra Merger, IRVINE, California, ... an orthobiologics company, today reported that,less than 100,000 votes ... Integra LifeSciences Holdings Corporation (NASDAQ: IART ),("Integra") pursuant ... of August,6, 2007. Today,s special meeting of stockholders ...
Other Biology Technology:CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 2IsoTis Reports Status of Merger Vote 2IsoTis Reports Status of Merger Vote 3IsoTis Reports Status of Merger Vote 4
(Date:12/14/2009)... WAYNE, Pa., Dec. 14 MODA Technology ... monitoring (EM), utility and product testing for the ... MODA 3.0, the company,s third generation mobile data ... (QC) organizations to further automate their regulated manufacturing ... new capabilities: ,, Fully-Configurable Test Methods: ...
(Date:12/13/2009)... resolved a question about how a popular class ... biosensors that reveal previously hidden components of chemical ... and hallucinations characterize the illness, people with schizophrenia ... in a particular order, difficulties that interfere with ... well, said Lee Schroeder, a student in the ...
(Date:12/13/2009)... 10, 2009Researchers at The Scripps Research Institute have ... protein from an ancient family of enzymes can ... In addition to providing guidance for understanding other ... theoretical underpinning for the protein,s possible use for ... The research was published in the December 13, ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 1SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 2SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 3SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 4SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 5
... at San Antonio and Universidad Nacional Autonoma de ... agreement in cooperation in science to foster collaboration ... both universities will contribute to the $50,000 annual ... development. The funding will allow top scientists and ...
... ONTARIO -- Farmers and vineyard owners have a new ... parasitoid, or parasitic insect that kills its host, has ... fruit flies in vineyards. These tiny pest-devouring insects are ... the need for chemical pest management applications. , Jean ...
... one of the largest remaining blocks of tropical forest ... and threatened species underscoring the areas high biological diversity ... 2006 expedition to Ghanas Atewa Range Forest Reserve (Atewa) ... presented in a report made public today. , The ...
Other Biology News:UTSA and University in Mexico to collaborate in science research 2New, rare and threatened species discovered in Ghana 2New, rare and threatened species discovered in Ghana 3
... contains a unique β-agarose digesting enzyme developed ... intact DNA and RNA from low melting ... TAE, TBE, MOPS, or phosphate buffers. The ... TAE, TBE, MOPS, and phosphate electrophoresis buffers ...
... a unique β-agarose digesting enzyme developed at ... DNA and RNA from low melting point ... TBE, MOPS, or phosphate buffers. The gel ... TBE, MOPS, and phosphate electrophoresis buffers or ...
... Perhaps sheer in-house demand is causing ... want your precious antibody. This can cause ... • Receive royalties for your hard ... and let us build it up and ...
... sheer in-house demand is causing shortages in ... antibody. This can cause unwanted distractions, problems ... Receive royalties for your hard work and ... us build it up,and market it internationally. ...
Biology Products: